Microbiology Procedure
  Home  Link to us  Resources  Site map  Search  Language

Index >>Immunity >> Type II Cytotoxic Hypersensitivity

Type II Cytotoxic Hypersensitivity

Type II Cytotoxic Hypersensitivity - This type is a cell damaging or cell-destroying reaction that occurs when 19O reacts with antigens on the surfaces of cells. Complement is often activated and IgM may be involved but IgE does not participate, nor does degranulation of mast cells. The cells affected are known as target cells.

A well-known example of this type of hypersensitivity is the transfusion reaction that arises from the mixing of incompatible blood types.Before dealing with transfusion reactions, let us consider the blood groups in humans.

Blood groups - The ABO system Harvey discovered that repeated attempts to transfuse blood from one individual another led to diastrous  reactions. The reason for this becan1e known, Only when Landsteiner discovered the alloantigens of human RBCs in 1900. AlloAgs are cell surface Ags, i.e. present on surfaces of RBCs. These are ages encoded by polymorphic genes, so that various alleles are present indifferent individuals from the same species. In  1890s, there were observations showing that animal species could be distinguished by the reactions of their RBCs and serum proteins with specific antisera. Landsteiner sought to determine whether individuals of the same species could be distinguished in the same way. When individual samples of serum and RBCs from 22 human species were mixed in all possible combinations the red cells of some persons were found to be Clumped by the serum of certain other individuals that led to a classification of the subjects into four groups.

From the results Landsteiner concluded that

(I) The RBCs of any human carry one, both, or neither of two different Ags (or blood group substances),.A and B, and
(2) Antibodies (Abs) for these alloAgs (called alloAbs) are regularly present in the serum of those individuals who lack the corresponding alloAg and are never in the serum of those who possess it. The blood groups or types in human populations are named for the red cell Ags: group A has the A alloAg, group B has the B AlloAg, group 0 has neither, and in group AB each red cell has both A and B. The corresponding serum alloAbs are anti-A in group B persons and anti-B in group A; group 0 has both anti-A and anti-B; group AB has neither.

The ABO gene has three alleles - A, B, and 0 - with A and B dominant over O. Since man is diploid, the two alleles per individual provide the six genotypes and four phenotypes as follows: Four major blood types are thus known: A,B,AB, and O. Each type is distinguished by certain antigens on the surface of. the erythrocytes and certain antibodies in the plasma. Before transfusion, it is important that the blood types of participants are determined so that incompatible types are not mixed. For instance, if a Type A blood donates to a recipient whose

Type is 0 the A antigens on the donor's erythrocytes will react with a antibodies in the recipeint plasma and the cytotoxic effect will be expressed as agglutination of donor erythrocytes in the recipients circulatory system. If the conditions are reversed, the donor's A antibodies will react to a lesser degree with the recipient's A antigens, because dilution in the recipeint's plasma takes place. The older notions that Type 0 blood is the universal donor and that type AB- is the universal recipient are mostly untenable. It is always desirable to cross-match the donor's erythrocytes with the recipient's plasma as well as the reverse, to ensure compatibility.

Another common expression of this type of hypersensitivity is hemolytic disease of the newborn or Rh disease. Erythocytes of some persons contain an antigen first described in rhesus monkeys and therefore known as Rh antigen. These persons are said to be Rh-positive and those lacking it as Rh-negative. Infact the antigen is a group of antigens which vary among Rh-positive individuals. However, here we will consider it as a single factor. Rh antigen producing ability is an inherited trait. If an Rh-negative woman marries an Rh-positive man, there is a 3 to I chance or 75% probability that the trait will be passed to the child and that the child will be Rh-positive.

Normally, a woman's circulatory system is exposed to her child's blood during the birth process, and if the child is Rh-­positive, its antigens enter her blood and stimulate her immune system to producerh antibodies. If a succeeding pregnancy results in another Rh­-positive child" these antibodies will cross the placents (along with other antibod­ies) and enter the fetal circulation. There they will react with the Rh antigens on the fetal erythrocytes and cause complement-mediated lysis of the cells. The fetal circulatory system rapidly releases immature erythroblasts to replace the lysed blood cells, but these are also destoryed.

From this observation the old name of disease is erythroblastosis fetalis. The result may be still birth. Modern treatment for hemolytic disease of newborn is injection of rh antibodies (RhoGAM) into the-woman within 72 hours of delivery of an Rh-positive child. Antibodies in the preparation injected interact with Rh antigens and remove them from the circulation thereby preventing stimulation of the woman's immune system. It should, however, be noted that an Rh-negative woman may produce rh antibodies as a result of abortion of an Rh-positive fetus or after a transfusion with Rh-positive blood.

Home | Site map | Submit Article | Resources | Search